Intuitive Surgical, Inc. (NASDAQ:ISRG) Position Cut by Spectrum Wealth Counsel LLC

Spectrum Wealth Counsel LLC lowered its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 8.0% during the 4th quarter, Holdings Channel reports. The fund owned 423 shares of the medical equipment provider’s stock after selling 37 shares during the period. Spectrum Wealth Counsel LLC’s holdings in Intuitive Surgical were worth $221,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors also recently added to or reduced their stakes in ISRG. Howard Capital Management Group LLC raised its stake in shares of Intuitive Surgical by 4.5% during the third quarter. Howard Capital Management Group LLC now owns 2,125 shares of the medical equipment provider’s stock valued at $1,044,000 after purchasing an additional 92 shares in the last quarter. Pinnacle Associates Ltd. raised its stake in shares of Intuitive Surgical by 2.1% during the third quarter. Pinnacle Associates Ltd. now owns 2,552 shares of the medical equipment provider’s stock valued at $1,254,000 after purchasing an additional 53 shares in the last quarter. Goldstone Financial Group LLC bought a new stake in shares of Intuitive Surgical during the third quarter valued at about $235,000. AustralianSuper Pty Ltd raised its stake in shares of Intuitive Surgical by 9.7% during the third quarter. AustralianSuper Pty Ltd now owns 12,886 shares of the medical equipment provider’s stock valued at $6,331,000 after purchasing an additional 1,140 shares in the last quarter. Finally, Reston Wealth Management LLC bought a new stake in shares of Intuitive Surgical during the third quarter valued at about $205,000. Institutional investors and hedge funds own 83.64% of the company’s stock.

Insider Buying and Selling

In related news, Director Amal M. Johnson sold 4,635 shares of the stock in a transaction on Tuesday, January 28th. The stock was sold at an average price of $566.60, for a total transaction of $2,626,191.00. Following the completion of the sale, the director now directly owns 12,275 shares in the company, valued at approximately $6,955,015. This trade represents a 27.41 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CFO Jamie Samath sold 94 shares of the stock in a transaction on Wednesday, January 29th. The stock was sold at an average price of $571.11, for a total value of $53,684.34. Following the sale, the chief financial officer now owns 2,630 shares of the company’s stock, valued at approximately $1,502,019.30. This represents a 3.45 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 8,077 shares of company stock worth $4,620,025. Corporate insiders own 0.80% of the company’s stock.

Intuitive Surgical Stock Up 1.7 %

Shares of Intuitive Surgical stock opened at $573.15 on Friday. Intuitive Surgical, Inc. has a 12 month low of $364.17 and a 12 month high of $616.00. The business has a fifty day simple moving average of $569.87 and a 200-day simple moving average of $528.64. The stock has a market cap of $204.14 billion, a PE ratio of 89.42, a price-to-earnings-growth ratio of 5.85 and a beta of 1.39.

Analyst Ratings Changes

A number of equities research analysts recently weighed in on ISRG shares. Evercore ISI lifted their price objective on shares of Intuitive Surgical from $490.00 to $530.00 in a research note on Monday, January 27th. Erste Group Bank upgraded shares of Intuitive Surgical from a “hold” rating to a “buy” rating in a research report on Tuesday, November 19th. JPMorgan Chase & Co. boosted their price target on shares of Intuitive Surgical from $575.00 to $675.00 and gave the stock an “overweight” rating in a research report on Friday, January 24th. Bernstein Bank boosted their price target on shares of Intuitive Surgical from $655.00 to $700.00 and gave the stock an “overweight” rating in a research report on Monday, January 27th. Finally, Leerink Partners boosted their price target on shares of Intuitive Surgical from $490.00 to $548.00 in a research report on Monday, January 27th. One analyst has rated the stock with a sell rating, four have assigned a hold rating and sixteen have assigned a buy rating to the company’s stock. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average target price of $613.10.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.